Yokoyama Takeshi, Suzuki Ryoya, Mizuguchi Mineyuki
Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, Toyama 930-0914, Japan.
IUCrJ. 2021 Jan 1;8(Pt 1):131-138. doi: 10.1107/S2052252520015614.
Death-associated protein kinase 1 (DAPK1) is a large multidomain protein with an N-terminal serine/threonine protein kinase domain. DAPK1 is considered to be a promising molecular target for the treatment of Alzheimer's disease (AD). In the present study, the inhibitory potency of resveratrol (RSV), a dietary polyphenol found in red wine, against the catalytic activity of DAPK1 was investigated. Kinetic and fluorescent probe competitive binding analyses revealed that RSV directly inhibited the catalytic activity of DAPK1 by binding to the ATP-binding site. Crystallographic analysis of DAPK1 in complex with RSV revealed that the A-ring of RSV occupied the nucleobase-binding position. Determination of the binding mode provided a structural basis for the design of more potent DAPK1 inhibitors. In conclusion, the data here clearly show that RSV is an ATP-competitive inhibitor of DAPK1, encouraging speculation that RSV may be useful for the development of AD inhibitors.
死亡相关蛋白激酶1(DAPK1)是一种具有N端丝氨酸/苏氨酸蛋白激酶结构域的大型多结构域蛋白。DAPK1被认为是治疗阿尔茨海默病(AD)的一个有前景的分子靶点。在本研究中,对红酒中发现的一种膳食多酚白藜芦醇(RSV)对DAPK1催化活性的抑制效力进行了研究。动力学和荧光探针竞争结合分析表明,RSV通过与ATP结合位点结合直接抑制DAPK1的催化活性。DAPK1与RSV复合物的晶体学分析表明,RSV的A环占据了核碱基结合位置。结合模式的确定为设计更有效的DAPK1抑制剂提供了结构基础。总之,这里的数据清楚地表明RSV是DAPK1的ATP竞争性抑制剂,这引发了人们对RSV可能有助于开发AD抑制剂的推测。